Citation Impact
Citing Papers
Breast cancer
2019 Standout
Immunotherapy and targeted therapy combinations in metastatic breast cancer
2019
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
2004 Standout
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
2007 Standout
Breast cancer statistics, 2019
2019 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer
2003
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
1991 Standout
Breast cancer
2016 Standout
Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.
1997
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Rechallenging with anthracyclines and taxanes in metastatic breast cancer
2010
Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy
1999
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Is there a role for post-operative adjuvant radiation in breast cancer? Beautiful hypothesis versus ugly facts: 1987 Gilbert H. Fletcher lecture
1988
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
2012 StandoutNobel
Anthrazykline in der Krebstherapie
1997 Standout
Significance of histopatholoaical evaluation in primary therapy for breast cancer-recent trends in primary modality with pathological complete response(pCR) as endpoint
2004
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience
1999
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Etoposide in the management of metastatic breast cancer
1991
Anthracycline Antibiotics in Cancer Therapy
1994
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
2009 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
1988
Hypersensitivity reactions from antineoplastic agents
1987
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
1997
Male breast cancer
2006 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
1989
Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance
2001
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
1988
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Platinum Compounds in the Treatment of Advanced Breast Cancer
2001
Hypersensitivity reactions from taxol.
1990 Standout
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
1987
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
2013 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation
2001
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Idarubicin
1991
Autologous Bone Marrow Transplantation
1989
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
1998 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
1989
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
1989
5 Amidines and Guanidines in Medicinal Chemistry
1993
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
2003
Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation
2000
Bone marrow transplantation for malignant lymphoma
1987 StandoutNobel
Progress and controversies: Radiation therapy for invasive breast cancer
2013
Preoperative chemotherapy for women with operable breast cancer
2007
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
1999
The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery
1985
Mechanistic Studies on the Cu-Catalyzed Three-Component Reactions of Sulfonyl Azides, 1-Alkynes and Amines, Alcohols, or Water: Dichotomy via a Common Pathway
2008 StandoutNobel
Patient compliance with aggressive multimodal therapy in locally advanced breast cancer
1988
Additions to Metal-Activated Organonitriles
2002 Standout
A comparison of mitoxantrone and doxorubicin in breast cancer.
1986
Breast Cancer Treatment
2019 Standout
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
1999
Clinical studies of ABMT in non-Hodgkin's lymphoma
1986
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy
2005
Bone Marrow Transplant
1990 Standout
Mitoxantrone (novantrone): a review of experimental and early clinical studies
1983
Induction of spermidine/spermine N1-acetyltransferase by methylglyoxal bis(guanylhydrazone)
1985
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
2000
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
2006
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
1986
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse
1983
Pathological assessment of response to induction chemotherapy in breast cancer.
1986
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
2008
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis.
2004 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Recent advances in the biochemistry of polyamines in eukaryotes
1986 Standout
Works of Frank C. Schell being referenced
Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens
1981
High-dose AMSA and bone marrow rescue in patients with solid tumors.
1982
Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma
1982
Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer
1981
Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.
1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial
1984
Bisantrene, an active new drug in the treatment of metastatic breast cancer.
1983
Combination chemoimmunotherapy with FAC‐BCG for metastatic breast cancer: The impact of CMF maintenance chemotherapy
1981
Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
1981
Multimodal treatment of locoregionally advanced breast cancer
1983
Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
1983